These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29747794)

  • 1. Recommendations for the Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw: A Systematic Review.
    Aparecida Cariolatto F; Carelli J; de Campos Moreira T; Pietrobon R; Rodrigues C; Bonilauri Ferreira AP
    J Evid Based Dent Pract; 2018 Jun; 18(2):142-152. PubMed ID: 29747794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteonecrosis of the jaw associated with bisphosphonate therapy in primary osteoporosis. Review of the literature].
    Outeiriño-Fernández A
    An Sist Sanit Navar; 2013; 36(1):87-97. PubMed ID: 23648496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can children be affected by bisphosphonate-related osteonecrosis of the jaw? A systematic review.
    Duarte NT; Rech BO; Martins IG; Franco JB; Ortega KL
    Int J Oral Maxillofac Surg; 2020 Feb; 49(2):183-191. PubMed ID: 31447218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review.
    Weber JB; Camilotti RS; Ponte ME
    Lasers Med Sci; 2016 Aug; 31(6):1261-72. PubMed ID: 27025860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of bisphosphonate therapy on dental implant outcomes: An overview of systematic review evidence.
    Mendes V; Dos Santos GO; Calasans-Maia MD; Granjeiro JM; Moraschini V
    Int J Oral Maxillofac Surg; 2019 Mar; 48(3):373-381. PubMed ID: 30314708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.
    Fliefel R; Tröltzsch M; Kühnisch J; Ehrenfeld M; Otto S
    Int J Oral Maxillofac Surg; 2015 May; 44(5):568-85. PubMed ID: 25726090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review.
    Lopez-Jornet P; Sanchez Perez A; Amaral Mendes R; Tobias A
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1067-72. PubMed ID: 27318752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ).
    Rupel K; Ottaviani G; Gobbo M; Contardo L; Tirelli G; Vescovi P; Di Lenarda R; Biasotto M
    Oral Oncol; 2014 Nov; 50(11):1049-57. PubMed ID: 25240948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the utility of serum C-telopeptide cross-link of type 1 collagen as a predictor of bisphosphonate-related osteonecrosis of the jaw: A systematic review and meta-analysis.
    Enciso R; Keaton J; Saleh N; Ahmadieh A; Clark GT; Sedghizadeh PP
    J Am Dent Assoc; 2016 Jul; 147(7):551-560.e11. PubMed ID: 27040417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the C-terminal telopeptide test in predicting the development of bisphosphonate-related osteonecrosis of the jaw: a systematic review.
    Dal Prá KJ; Lemos CA; Okamoto R; Soubhia AM; Pellizzer EP
    Int J Oral Maxillofac Surg; 2017 Feb; 46(2):151-156. PubMed ID: 27876532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses.
    Karna H; Gonzalez J; Radia HS; Sedghizadeh PP; Enciso R
    Oral Oncol; 2018 Oct; 85():15-23. PubMed ID: 30220314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta.
    Hennedige AA; Jayasinghe J; Khajeh J; Macfarlane TV
    J Oral Maxillofac Res; 2013 Oct; 4(4):e1. PubMed ID: 24478911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate-induced osteonecrosis of the jaw.
    Krueger CD; West PM; Sargent M; Lodolce AE; Pickard AS
    Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.
    Silva LF; Curra C; Munerato MS; Deantoni CC; Matsumoto MA; Cardoso CL; Curi MM
    Oral Maxillofac Surg; 2016 Mar; 20(1):9-17. PubMed ID: 26659615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
    Del Fabbro M; Gallesio G; Mozzati M
    Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of Korean dentists on the awareness on bisphosphonate-related osteonecrosis of the jaws.
    Yoo JY; Park YD; Kwon YD; Kim DY; Ohe JY
    J Investig Clin Dent; 2010 Nov; 1(2):90-5. PubMed ID: 25427263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bisphosphonate-related osteonecrosis of the jaw].
    Atanes-Bonome P; Atanes-Bonome A; Ríos-Lage P; Atanes-Sandoval AD
    Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.